TY - JOUR
T1 - Management of neurological complications of carotid artery stenting
AU - Wholey, M. H.
AU - Wholey, M. H.
AU - Tan, W. A.
AU - Toursarkissian, B.
AU - Bailey, S.
AU - Eles, G.
AU - Jarmolowski, C.
PY - 2001/9/12
Y1 - 2001/9/12
N2 - Purpose: To review the neurological complications associated with extracranial carotid artery stenting and to preliminarily assess techniques used to manage these complications. Methods: Between April 1994 and August 2000, 450 patients (270 men; mean age 70.2 years, range 27-89) had stents implanted to treat 472 cervical carotid artery stenoses. Over half (257, 57%) of the patients were symptomatic. A variety of stents were implanted percutaneously after predilation of the lesion; a third of the patients received glycoprotein IIb/IIIa inhibitors intraprocedurally in addition to a standard oral antiplatelet regimen (aspirin and ticlopidine or clopidogrel). Occurrence and management of neurological complications within the 30-day periprocedural period were reviewed. Results: There were 14 (3.1%) transient ischemic attacks (TIAs), 10 (2.2%) minor strokes, and 3 (0.7%) major strokes. Among 6 (1.3%) procedure-related deaths, 4 had neurological causes. The total stroke and death rate was 4.2% (n =19). All the TIAs, 4 of which occurred between 1 and 14 days poststenting, were treated medically, as were the minor strokes, 3 of which occurred >24 hours after stenting. Only 2 minor stroke patients had mild residual upper extremity motor deficits. Intra-arterial thrombolytic therapy was administered in 5 cases (2 major strokes survivors and 3 patients who suffered a neurologically-related death); occlusions were identified in the proximal middle cerebral artery (MCA) in 3 and the distal MCA in 2. Angiographic improvement was noted in 4 (80%), but only the 2 (40%) with distal MCA occlusions did well clinically. Conclusions: Neurological complications following carotid artery stenting are inevitable. The occurrence of minor strokes >24 hours following stenting may indicate a possible late embolic phenomenon, which warrants investigation. Likewise, the marginal efficacy of intra-arterial thrombolytic therapy demonstrates an inability to lyse embolic plaque and underscores the need for effective distal protection.
AB - Purpose: To review the neurological complications associated with extracranial carotid artery stenting and to preliminarily assess techniques used to manage these complications. Methods: Between April 1994 and August 2000, 450 patients (270 men; mean age 70.2 years, range 27-89) had stents implanted to treat 472 cervical carotid artery stenoses. Over half (257, 57%) of the patients were symptomatic. A variety of stents were implanted percutaneously after predilation of the lesion; a third of the patients received glycoprotein IIb/IIIa inhibitors intraprocedurally in addition to a standard oral antiplatelet regimen (aspirin and ticlopidine or clopidogrel). Occurrence and management of neurological complications within the 30-day periprocedural period were reviewed. Results: There were 14 (3.1%) transient ischemic attacks (TIAs), 10 (2.2%) minor strokes, and 3 (0.7%) major strokes. Among 6 (1.3%) procedure-related deaths, 4 had neurological causes. The total stroke and death rate was 4.2% (n =19). All the TIAs, 4 of which occurred between 1 and 14 days poststenting, were treated medically, as were the minor strokes, 3 of which occurred >24 hours after stenting. Only 2 minor stroke patients had mild residual upper extremity motor deficits. Intra-arterial thrombolytic therapy was administered in 5 cases (2 major strokes survivors and 3 patients who suffered a neurologically-related death); occlusions were identified in the proximal middle cerebral artery (MCA) in 3 and the distal MCA in 2. Angiographic improvement was noted in 4 (80%), but only the 2 (40%) with distal MCA occlusions did well clinically. Conclusions: Neurological complications following carotid artery stenting are inevitable. The occurrence of minor strokes >24 hours following stenting may indicate a possible late embolic phenomenon, which warrants investigation. Likewise, the marginal efficacy of intra-arterial thrombolytic therapy demonstrates an inability to lyse embolic plaque and underscores the need for effective distal protection.
KW - Carotid stenosis
KW - Palmaz stent
KW - Stroke
KW - Thrombolysis
KW - Transient ischemic attack
UR - http://www.scopus.com/inward/record.url?scp=0034862834&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034862834&partnerID=8YFLogxK
U2 - 10.1583/1545-1550(2001)008<0341:MONCOC>2.0.CO;2
DO - 10.1583/1545-1550(2001)008<0341:MONCOC>2.0.CO;2
M3 - Article
C2 - 11552726
AN - SCOPUS:0034862834
SN - 1526-6028
VL - 8
SP - 341
EP - 353
JO - Journal of Endovascular Therapy
JF - Journal of Endovascular Therapy
IS - 4
ER -